Background Increased expression of TRPV1 receptors in the airways of chronic cough patients and heightened cough responses to inhaled capsaicin are suggestive of a role for TRPV1 receptors in chronic ...

Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA Correspondence to Dr S Guerra, Arizona Respiratory Center, University of Arizona, 1501 N. Campbell Ave, PO ...

Chronic cough (CC) is common, predominantly affecting middle-aged females. Sufferers experience significantly impaired quality of life (QoL). Cough is associated with increased healthcare costs.

The British Thoracic Society (BTS) Home Oxygen Guideline provides detailed evidence-based guidance for the use of home oxygen for patients out of hospital. Although the majority of evidence comes from ...

Background The aim of this study was to estimate the long-term (cost-) effectiveness of smoking cessation interventions for patients with chronic obstructive pulmonary disease (COPD). Methods A ...

Rationale Pulmonary rehabilitation (PR) is an effective, key standard treatment for people with COPD. Nevertheless, low participant uptake, insufficient attendance and high drop-out rates are reported ...

Background Many studies show a link between forced expiratory volume in 1 s (FEV 1) and survival in the general population and this has been interpreted as a link between airway obstruction and ...

a Inflammation Research Unit, School of Pathology, University of New South Wales, Sydney, Australia 2052, b Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, ...

Background Prior work suggests different interstitial lung diseases (ILDs) that share the radiological usual interstitial pneumonia (UIP) pattern have an overall worse prognosis. However, ...

Climate change is altering ecosystems worldwide. While shifting environmental conditions are complex, it has been hypothesised that the impact of climate change is directly leading to increases in ...

Rationale The most common antibiotic used to treat people with cystic fibrosis (PWCF) is inhaled tobramycin, administered as maintenance therapy for chronic Pseudomonas aeruginosa lung infections.